We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Bankunited
BKU
$3.39B
| $980K | 0.03% |
+27,187
| New | +$1.01M |
|
677
Owens Corning
OC
$11.5B
| $975K | 0.03% |
20,727
+11,554
| +126% | +$530K |
|
678
Valmont Industries
VMI
$9.33B
| $973K | 0.03% |
+9,180
| New | +$995K |
|
|
TYC
679
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $969K | 0.03% |
29,020
+2,675
| +10% | +$97.7K |
|
680
Genpact
G
$5.87B
| $966K | 0.03% |
38,722
-18,843
| -33% | -$466K |
|
681
National Bank Holdings
NBHC
$1.9B
| $961K | 0.03% |
+44,975
| New | +$973K |
|
682
CALL
Aflac
AFL
$65.9B
| $958K | 0.03% |
32,000
+8,000
| +33% | +$249K |
|
|
683
PUT
Aflac
AFL
$65.9B
| $958K | 0.03% |
32,000
+8,000
| +33% | +$249K |
|
|
PRXL
684
DELISTED
Parexel International Corp
PRXL
| $955K | 0.03% |
+14,019
| New | +$912K |
|
685
Goodyear
GT
$2.12B
| $954K | 0.03% |
29,192
+7,763
| +36% | +$255K |
|
686
Abercrombie & Fitch
ANF
$4.58B
| $953K | 0.03% |
+35,287
| New | +$819K |
|
687
Leidos
LDOS
$14.9B
| $953K | 0.03% |
16,942
-13,664
| -45% | -$720K |
|
|
WNR
688
DELISTED
Western Refining Inc
WNR
| $945K | 0.03% |
26,526
+19,923
| +302% | +$853K |
|
689
CALL
UnitedHealth
UNH
$389B
| $941K | 0.02% |
8,000
-4,000
| -33% | -$468K |
|
|
690
PUT
UnitedHealth
UNH
$389B
| $941K | 0.02% |
8,000
-4,000
| -33% | -$468K |
|
691
CALL
Union Pacific
UNP
$175B
| $938K | 0.02% |
12,000
| – | – |
|
|
692
PUT
Union Pacific
UNP
$175B
| $938K | 0.02% |
12,000
| – | – |
|
693
Carnival Corporation Ltd
CCL
$38.7B
| $931K | 0.02% |
17,097
-24,395
| -59% | -$1.26M |
|
694
CALL
Dollar Tree
DLTR
$24.4B
| $927K | 0.02% |
+12,000
| New | +$839K |
|
|
695
PUT
Dollar Tree
DLTR
$24.4B
| $927K | 0.02% |
+12,000
| New | +$839K |
|
696
Hilton Worldwide
HLT
$72.6B
| $922K | 0.02% |
14,373
+9,623
| +203% | +$684K |
|
|
SNCR
697
DELISTED
Synchronoss Technologies
SNCR
| $922K | 0.02% |
2,906
+366
| +14% | +$121K |
|
698
UMB Financial
UMBF
$10.9B
| $922K | 0.02% |
+19,815
| New | +$1M |
|
|
BIG
699
DELISTED
Big Lots, Inc.
BIG
| $921K | 0.02% |
23,888
-2,061
| -8% | -$91.5K |
|
700
Allison Transmission
ALSN
$10B
| $920K | 0.02% |
35,505
-11,723
| -25% | -$320K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.